This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Nexel Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Donghun Woo
Introduction
Donghun Woo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of cardiac safety and pulmonary health. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Donghun Woo's latest patents include a polypeptide designed for preventing or treating idiopathic pulmonary fibrosis. This innovative approach aims to address a critical health issue affecting many individuals. Additionally, he has developed methods for evaluating the cardiac safety of drugs using cardiomyocytes derived from human stem cells. This method involves several steps, including the preparation of cardiomyocytes, dilution of fibronectin, and measurement of various parameters to assess drug effects.
Career Highlights
Donghun Woo is currently associated with Nexel Co., Ltd., where he continues to advance his research and innovations. His work is characterized by a commitment to improving drug safety and efficacy, which is crucial for patient care.
Collaborations
He collaborates with talented coworkers, including Jieun An and Subin Kim, who contribute to his research efforts and help drive innovation within the company.
Conclusion
Donghun Woo's contributions to the field of pharmaceuticals highlight his dedication to improving health outcomes through innovative research. His patents reflect a commitment to advancing medical science and enhancing drug safety.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile